Japan’s 2025 ‘Off-Year’ Price Cut Stirs Deeper Concerns
Move Will Cut $1.6bn From Drugs Bill
Multiple industry groups in Japan warn that a decision to implement an "off-year" drug price revision in April will reverse other recent policy moves to support innovation.
